Clinical studies recruiting near Nanchang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · The First Affiliated Hospital of Nanchang University · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Jiangxi Maternal and Child Health Hospital · Daiichi Sankyo · NCT07022483 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · The First Affiliated Hospital of Nanchang University ( Site · Merck Sharp & Dohme LLC · NCT06136559 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · Jiangxi Cancer Hospital · Sun Yat-sen University · NCT05941741 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · The First Affiliated Hospital of Nanchang University · Bristol-Myers Squibb · NCT07106762 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The First Affiliated Hospital of Nanchang University · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Affiliated Hospital of Nanchang University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · The Second Affiliated Hospital of Nanchang University /ID# 2 · AbbVie · NCT06487559 Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Phase N/A · First Affiliated Hospital of Nanchang University · Xingshun Qi · NCT04662918 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · The First Affiliated Hospital of Nanchang University · Boehringer Ingelheim · NCT07355296 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · The First Affiliated Hospital of Nanchang University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Clinical Trial of TQB3002 in Patients With Advanced Cancers
Phase 1 · The First Affiliated Hospital Of Nanchang University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06662760 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · The First Affiliated Hospital of Nanchang University · Takeda · NCT06671496 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Jiangxi Cancer Hospital · Shanghai Henlius Biotech · NCT07160335 The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · Jiangxi Provincial People's Hospital · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0123 · Bristol-Myers Squibb · NCT07291076 The Chinese Familial Alzheimer's Network
Phase N/A · Jiangxi Provincial People's Hospital · Capital Medical University · NCT03657732 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The First Affiliated Hospital of Nanchang University · Amgen · NCT07037433 A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · Nanchang People's Hospital · Hasten Biopharmaceutical Co., Ltd. · NCT06568471 A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
Phase 1 · The First Affiliated Hospital Of Nanchang University · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT06615193 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · Jiangxi Cancer Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images
Phase N/A · The Second Affiliated Hospital of Nanchang University · Second Affiliated Hospital of Nanchang University · NCT06669728 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigative Site: 1560004 · Sanofi · NCT06958536 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Jiangxi Provincial People's Hospital · Eli Lilly and Company · NCT07369011 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · The First Affiliated Hospital of Nanchang University · Amgen · NCT04221542 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · The Second Affiliated Hospital of Nanchang University · Pfizer · NCT05895786 A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of
Phase 1/Phase 2 · The Second Affiliated Hospital of Jiangxi University of Trad · Jiangxi University of Traditional Chinese Medicine · NCT07535983 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · The First Affiliated Hospital of Nanchang University · Pfizer · NCT07144280 Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
Phase 4 · The First Affiliated Hospital of Nanchang University · The First Affiliated Hospital of Nanchang University · NCT06118762

Look up another city

Look up another condition